Curi Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,186
Closed -$342K 9
2023
Q4
$342K Sell
1,186
-6
-0.5% -$1.64K 0.05% 113
2023
Q3
$320K Sell
1,192
-278
-19% -$69.4K 0.05% 109
2023
Q2
$326K Sell
1,470
-2,105
-59% -$488K 0.04% 122
2023
Q1
$864K Sell
3,575
-4
-0.1% -$982 0.12% 79
2022
Q4
$940K Sell
3,579
-1,362
-28% -$365K 0.13% 83
2022
Q3
$1.11M Buy
4,941
+3,779
+325% +$916K 0.18% 64
2022
Q2
$283K Buy
1,162
+63
+6% +$15.4K 0.05% 92
2022
Q1
$265K Buy
1,099
+390
+55% +$89.6K 0.05% 97
2021
Q4
$159K Buy
+709
New +$150K 0.03% 122
2021
Q2
Sell
-826
Closed -$205K 93
2021
Q1
$205K Buy
826
+32
+4% +$7.63K 0.13% 87
2020
Q4
$182K Buy
+794
New +$183K 0.13% 85

Other funds holding AMGN

Curi Wealth Management's AMGN Position: Q1 2024 in Review

Curi Wealth Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 1,186 shares — an estimated $342K sold.

Curi Wealth Management first reported a position in AMGN in Q4 2020 and held it in 11 quarters. The position peaked at $1.11M in Q3 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Curi Wealth Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Curi Wealth Management sold 1,186 Amgen shares in Q1 2024, an estimated $342K.
  • Curi Wealth Management first reported a position in Amgen in Q4 2020 and held it in 11 quarters.
  • Curi Wealth Management's Amgen position peaked at $1.11M in Q3 2022.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Curi Wealth Management's 13F filing for Q1 2024.